Guillain-Barré syndrome.
The concepts of Guillain-Barré syndrome have changed substantially over the last 10 years, and the last 2 years have been no exception. Guillain-Barré syndrome is now recognized as a heterogeneous disorder with many clinical manifestations. Most current investigations are centered on the hypothesis of molecular mimicry. The major challenge now is to identify the precise mechanisms of nerve fiber injury and to determine how to prevent immune injury.
Ho
T
T
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Griffin
J
J
D000941:Antigens / Q000276:immunology; D002169:Campylobacter Infections / Q000150:complications / Q000276:immunology; D004198:Disease Susceptibility; D005759:Gastroenteritis / Q000382:microbiology; D020275:Guillain-Barre Syndrome / Q000175:diagnosis* / Q000453:epidemiology* / Q000276:immunology; D006801:Humans
D000941:Antigens